Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/14/1339   
Active ingredient: Cannabidiol
Indication: Treatment of Dravet syndrome
Sponsor: GW Research Ltd
Sovereign House, Vision Park, Chivers Way, Histon, Cambridge CB24 9BZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/083/14 (2014)7638 of 15/10/2014
28/05/2015 Change of name and/or address of sponsor
20/11/2017 Transfer of orphan designation EMA/OD/083/14/T/01 (2017)7798 of 16/11/2017